UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2022	$ 36	$ 251	$ (12,039)	$ 126,006	$ 114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	21	0	0	21
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	50	0	0	50
Foreign currency translation adjustment	0	0	549	0	549
Common stock dividends	0	0	0	(1,070)	(1,070)
Net income	0	0	0	4,214	4,214
Equity Balance, value at Mar. 31, 2023	$ 36	322	(11,491)	129,150	118,018
Equity Balance, shares at Mar. 31, 2023	3,628
Equity Balance, value at Dec. 31, 2022	$ 36	251	(12,039)	126,006	114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Foreign currency translation adjustment					1,053
Net income					8,414
Equity Balance, value at Jun. 30, 2023	$ 36	432	(10,986)	132,279	121,761
Equity Balance, shares at Jun. 30, 2023	3,629
Equity Balance, value at Mar. 31, 2023	$ 36	322	(11,491)	129,150	118,018
Equity Balance, shares at Mar. 31, 2023	3,628
Common stock issued upon exercise of employee stock options	$ 0	60	0	0	60
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	50	0	0	50
Foreign currency translation adjustment	0	0	504	0	504
Common stock dividends	0	0	0	(1,071)	(1,071)
Net income	0	0	0	4,200	4,200
Equity Balance, value at Jun. 30, 2023	$ 36	432	(10,986)	132,279	121,761
Equity Balance, shares at Jun. 30, 2023	3,629
Equity Balance, value at Dec. 31, 2023	$ 36	593	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options	$ 0	96	0	0	96
Common stock issued upon exercise of employee stock options, shares	2
Stock option compensation expense	$ 0	79	0	0	79
Common stock purchased and retired	$ 0	(769)	0	(2,221)	(2,990)
Common stock purchased and retired, shares	(43)
Foreign currency translation adjustment	$ 0	0	(631)	0	(631)
Common stock dividends	0	0	0	(1,081)	(1,081)
Net income	0	0	0	3,956	3,956
Equity Balance, value at Mar. 31, 2024	$ 36	0	(11,289)	138,995	127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Equity Balance, value at Dec. 31, 2023	$ 36	593	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Foreign currency translation adjustment					(664)
Net income					7,409
Equity Balance, value at Jun. 30, 2024	$ 35	0	(11,322)	135,339	124,052
Equity Balance, shares at Jun. 30, 2024	3,499
Equity Balance, value at Mar. 31, 2024	$ 36	0	(11,289)	138,995	127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Common stock issued upon exercise of employee stock options	$ 0	294	0	0	294
Common stock issued upon exercise of employee stock options, shares	6
Stock option compensation expense	$ 0	52	0	0	52
Common stock purchased and retired	$ (1)	(346)	0	(6,056)	(6,403)
Common stock purchased and retired, shares	(95)
Foreign currency translation adjustment	$ 0	0	(33)	0	(33)
Common stock dividends	0	0	0	(1,052)	(1,052)
Net income	0	0	0	3,453	3,453
Equity Balance, value at Jun. 30, 2024	$ 35	$ 0	$ (11,322)	$ 135,339	$ 124,052
Equity Balance, shares at Jun. 30, 2024	3,499